GLP-1 Stocks to Watch: Eli Lilly Among Top Contenders

The Motley Fool has identified the top GLP-1 stocks for 2026, and Eli Lilly is among them. GLP-1, or glucagon-like peptide-1, is a type of medication used to treat diabetes and obesity.

According to the article, Eli Lilly, Novo Nordisk, Amgen, Merck, and Roche Holding AG are among the top GLP-1 stocks for 2026. These companies have been investing heavily in research and development of new GLP-1 medications.

The Motley Fool recommends these stocks due to their strong pipelines, established track records, and competitive market positions. However, it is essential to note that past performance is not a guarantee of future success.